Filter posts

Meeting India's Biotech Community

Biotechnology is a global enterprise.  The United States continues to play the dominant role but …

Encouraging Louisiana to Partner with BIO

Louisiana is one of just a few states that do not yet have a BIO …

Protection against Seasonal Flu

Today, BIO offered seasonal flu vaccines to all employees, many of whom joined me in …

Biotech Advances in South Dakota

Last week I made my first visit to our South Dakota affiliate. The South Dakota …

Touring Local Biotech Companies with Former Governor Dean

Last week I spent a fascinating day with former Vermont Governor Howard Dean and three …

Jim Greenwood guest appearance on CNBC’s “Squawk Box” during this morning’s “Health Care S...

BIO President and CEO Jim Greenwood joined former HHS Secretary Tommy Thompson and former FDA …

Clearing Another Hurdle on the Pathway to Biosimilars

The House Energy and Commerce Committee, by a vote of 47 to 11, overwhelmingly adopted …

Patient groups join call for data protection

Biomedical innovation is not only key to our industry’s future, but more importantly, continued medical …

Victory on Biosimilars in Senate HELP Committee - But Still a Long Way from the Finish Line

Last evening the Senate Health, Education, Labor and Pensions (HELP) Committee adopted an amendment to …

The Washington Post: Special section on biotechnology

As part of our public education/industry branding campaign, BIO sponsored a special section on biotechnology …